# BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF

> **NCT04434664** · PHASE4 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 50 (actual)

## Conditions studied

- Heart Failure With Preserved Ejection Fraction
- Hypertension

## Interventions

- **DRUG:** Amlodipine Besylate
- **DRUG:** Metoprolol Succinate

## Key facts

- **NCT ID:** NCT04434664
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-01
- **Primary completion:** 2024-12-03
- **Final completion:** 2024-12-20
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04434664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04434664, "BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04434664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*